m+Medelevator.RU
← Поиск публикаций
American heart journal · 2018

Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trial.

СтатьяПротокол клинического исследованияНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Desch Steffen, Freund Anne, Graf Tobias, Fichtlscherer Stephan, Haake Hendrik, Preusch Michael, Hammer Fabian, Akin Ibrahim, Christ Martin, Liebetrau Christoph, Skurk Carsten, Steiner Stephan, Voigt Ingo, Schmitz Roland, Mudra Harald, Ledwoch Jakob, Menck Niels, Horstkotte Jan, Pels Klaus, Lahmann Anna-Lena, Otto Sylvia, Lenk Karsten, Ohlow Marc-Alexander, Hassager Christian, Nordbeck Peter, Zeymer Uwe, Jobs Alexander, de Waha-Thiele Suzanne, Olbrich Denise, König Inke, Klinge Kathrin, Thiele Holger

Аннотация

Patients experiencing out-of-hospital cardiac arrest (OHCA) without ST-segment elevation are a heterogenic group with a variety of underlying causes. Up to one-third of patients display a significant coronary lesion compatible with myocardial infarction as OHCA trigger. There are no randomized data on patient selection and timing of invasive coronary angiography after admission. METHODS AND RESULTS: The TOMAHAWK trial randomly assigns 558 patients with return of spontaneous circulation after OHCA with no obvious extracardiac origin of cardiac arrest and no ST-segment elevation/left bundle-branch block on postresuscitation electrocardiogram to either immediate coronary angiography or initial intensive care assessment with delayed/selective angiography in a 1:1 ratio. The primary end point is 30-day all-cause mortality. Secondary analyses will be performed with respect to initial rhythm, electrocardiographic patterns, myocardial infarction as underlying cause, neurological outcome, as well as clinical and laboratory markers. Clinical follow-up will be performed at 6 and 12 months. Safety end points include bleeding and stroke. CONCLUSION: The TOMAHAWK trial will address the unresolved issue of timing and general indication of angiography after OHCA without ST-segment elevation.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты